These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4917428)

  • 1. Ethacrynic acid alone and in combination with methyldopa in the management of mild hypertension. A report of 23 patients.
    Gifford RW
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):255-60. PubMed ID: 4917428
    [No Abstract]   [Full Text] [Related]  

  • 2. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypotensive action of ethacrynic acid.
    Hutchison JC
    Vasc Dis; 1968 Jun; 5(2):104-17. PubMed ID: 4871800
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-range therapy of hypertension].
    Szám I; Radó J; Takó J
    Z Gesamte Inn Med; 1976 Feb; 31(3):321-4. PubMed ID: 960892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of guanethidine and hydrochlorothiazide in the treatment of arterial hypertension with and without renal failure.
    Muiesan G; Motolese M; Petz E; Todisco T
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):489-94. PubMed ID: 4887948
    [No Abstract]   [Full Text] [Related]  

  • 7. Methyldopa combined with prindolol in the treatment of severe hypertension.
    Seedat YK
    S Afr Med J; 1974 Aug; 48(38):1608-10. PubMed ID: 4615382
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical observations with the new saluretic 2,3-dichlor-4-(2-methylene-butryl-phenoxy-acetic acid (ethacrynic acid)].
    Frank H
    Arzneimittelforschung; 1966 Mar; 16(3):380-3. PubMed ID: 6013849
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the antihypertensive efficacy of acebutolol, chlorthalidone and the combination of acebutolol and chlorthalidone in the treatment of mild and moderate primary arterial hypertension].
    Del Nero Júnior E; Lima EV; Savioli RM; de Rezende MC
    Arq Bras Cardiol; 1983 May; 40(5):357-61. PubMed ID: 6360100
    [No Abstract]   [Full Text] [Related]  

  • 10. [Report on clinical trial of Lanitop].
    Steinorth G; Schweers A
    Med Welt; 1973 Aug; 24(35):1310-7. PubMed ID: 4591056
    [No Abstract]   [Full Text] [Related]  

  • 11. [Report on the clinical testing of the Sembrina--Saltucin. Drug combination for the treatment of hypertension].
    Holler HD; Steinorth G
    Med Welt; 1969 Oct; 42():2306-14. PubMed ID: 5355675
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of a new antihypertensive combination (cyclazenine + presinol)].
    Ambrosioni E
    G Clin Med; 1967 Nov; 48(11):1149-62. PubMed ID: 5617984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Xipamide in the treatment of mild to moderate systemic arterial hypertension].
    Ramos NB; Guimarães AC
    Arq Bras Cardiol; 1984 Jul; 43(1):71-5. PubMed ID: 6395840
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the effects of hydrochlorothiazide and of frusemide in the treatment of hypertensive patients.
    Anderson J; Godfrey BE; Hill DM; Munro-Faure AD; Sheldon J
    Q J Med; 1971 Oct; 40(160):541-60. PubMed ID: 4945546
    [No Abstract]   [Full Text] [Related]  

  • 15. [MK 87O. A new potassium-retaining diuretic].
    Juul J; Nielsen FU
    Ugeskr Laeger; 1968 Jan; 130(2):45-51. PubMed ID: 4871599
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experiences with methyldopa.
    Pessina AC; Pigato R; Palù CD
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():51-4. PubMed ID: 354829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects.
    Holmes EL
    Ann Phys Med; 1966; Suppl():36-49. PubMed ID: 4895006
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of spironolactone (Aldactone) and methyldopa in low and normal renin hypertension.
    Solheim SB; Sundsfjord JA; Giezendanner L
    Acta Med Scand; 1975 Jun; 197(6):451-6. PubMed ID: 1098396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of hypertension with methyldopa. VIII. Overview.
    Itskovitz HD
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S120-7. PubMed ID: 6172668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and hypotensive effects of ethacrynic acid. Comparative study with hydrochlorothiazide.
    Russell RP; Lindeman RD; Prescott LF
    JAMA; 1968 Jul; 205(1):81-5. PubMed ID: 5694972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.